Literature DB >> 14962827

Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells.

Weike Mao1, Fuzhong Qin, Chikao Iwai, Raju Vulapalli, Peter C Keng, Chang-seng Liang.   

Abstract

Cardiac norepinephrine (NE) uptake activity is reduced in congestive heart failure. Our studies in intact animals suggest that this effect on the cardiac sympathetic nerve endings is caused by oxidative stress and/or NE toxic metabolites derived from NE. In this study, we investigated the direct effects of NE on neuronal NE uptake activity and NE transporter (NET), using undifferentiated PC12 cells. Cells were incubated with NE (1-500 microM) either alone or in combination of Cu(2+) sulfate (1 microM), which promotes free radical formation by Fenton reaction for 24 h. NE uptake activity was measured using [(3)H]NE. Cell viability was determined with the use of Trypan blue exclusion and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay, and cellular oxidative stress by dichlorodihydrofluorescein fluorescence and the GSH/GSSG ratio. Cell viability was reduced by NE >100 microM. At lower doses, NE produced oxidative stress and a dose-dependent reduction of NE uptake activity without affecting cell viability significantly. Cu(2+), which has no direct effect on NE uptake activity, potentiated oxidative stress and reduction of NE uptake activity produced by NE. This decrease of NE uptake activity was associated with reductions of NE uptake binding sites and NET protein expression by using the radioligand assay and Western blot analysis, but no changes in NET gene expression. In addition, the free-radical scavenger mannitol, and antioxidant enzymes superoxide dismutase and catalase, reduced oxidative stress and attenuated the reductions of NE uptake activity and NET protein produced by NE/Cu. Thus our results support a functional role of oxidative stress in mediating the neuronal NE uptake reducing effect of NE and that this effect of NE on NET is a posttranscriptional event.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962827     DOI: 10.1152/ajpheart.01168.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  6 in total

1.  Propranolol improves impaired hepatic phosphatidylinositol 3-kinase/akt signaling after burn injury.

Authors:  Natasha C Brooks; Juquan Song; Darren Boehning; Robert Kraft; Celeste C Finnerty; David N Herndon; Marc G Jeschke
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

2.  Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension.

Authors:  Erica A Wehrwein; Martin Novotny; Greg M Swain; Lindsay M Parker; Mohammad Esfahanian; John M Spitsbergen; Beth A Habecker; David L Kreulen
Journal:  Auton Neurosci       Date:  2013-08-31       Impact factor: 3.145

3.  Localization of NADPH oxidase in sympathetic and sensory ganglion neurons and perivascular nerve fibers.

Authors:  Xian Cao; Stacie L Demel; Mark T Quinn; James J Galligan; David Kreulen
Journal:  Auton Neurosci       Date:  2009-08-27       Impact factor: 3.145

4.  Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter.

Authors:  Michael M Kreusser; Lorenz H Lehmann; Markus Haass; Sebastian J Buss; Hugo A Katus; Dirk Lossnitzer
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

5.  Hyperinsulinaemic hypoglycaemia: A rare association of vanishing white matter disease.

Authors:  Carolyn Bursle; Eppie M Yiu; Alison Yeung; Jeremy L Freeman; Chloe Stutterd; Richard J Leventer; Adeline Vanderver; Joy Yaplito-Lee
Journal:  JIMD Rep       Date:  2019-11-12

6.  Altered expression of norepinephrine transporter and norepinephrine in human placenta cause pre-eclampsia through regulated trophoblast invasion.

Authors:  Kyu-Hwan Na; Jong Ho Choi; Chun-Hyung Kim; Kwang-Soo Kim; Gi Jin Kim
Journal:  Clin Exp Reprod Med       Date:  2013-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.